Anthem Bioscienc (ANTHEM)
STALWARTFairStock Score: 19/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹740.55 |
| Market Cap | ₹39,390.18 Cr |
| P/E Ratio | 78.36 |
| ROCE | 28.5% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -10.85% |
| Debt/Equity | 0.04 |
| Sales Growth | -15% |
| Free Cash Flow | ₹26,600 Cr |
| Promoter Holding | 74.69% |
| 52-Week Range | ₹579.15 — ₹873.5 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹51.55 |
Anthem Bioscienc trades with a P/E ratio of 78.36, ROCE of 28.5%, profit growth of -10.85%, debt-to-equity of 0.04. The FairStock Score of 19/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer